Investors Press Releases May 28 2026 Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York Read More May 21 2026 Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial Read More May 19 2026 Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Read More btn News View All Events & Presentations Dec 16 2025 at 8:30 AM EST Dec 16 2025 at 8:30 AM EST Annual General Meeting 2025 Read More Dec 12 2024 at 8:30 AM EST Dec 12 2024 at 8:30 AM EST Annual General Meeting 2024 Read More Dec 14 2023 at 8:30 AM EST Dec 14 2023 at 8:30 AM EST Annual General Meeting 2023 Read More btn Events View All Interim Reports Interim Results for the Six Months Ended 30 June 2025 721.5 KB bth Interim Reports View All Annual Reports 20 F - Annual Report for the year ended 31 December 2024 1.4 MB btn ARs View All Annual General Meeting 2025 AGM Results 60.5 KB btn AGM View All Stock Quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low Stock Chart
May 28 2026 Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York Read More
May 19 2026 Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Read More